Royalty Pharma Plc (RPRX)
44.65
+0.55
(+1.25%)
USD |
NASDAQ |
Feb 06, 16:00
44.65
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Market Cap : 19.08B for Feb. 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Denali Therapeutics, Inc. | 3.292B |
| Eli Lilly & Co. | 947.09B |
| PTC Therapeutics, Inc. | 5.996B |
| Incyte Corp. | 21.28B |
| Ultragenyx Pharmaceutical, Inc. | 2.383B |
Market Cap Related Metrics
| PE Ratio | 25.53 |
| PS Ratio | 10.87 |
| Price to Book Value | 2.974 |
| Price to Free Cash Flow | 24.38 |
| Price | 44.65 |
| Earnings Yield | 3.92% |
| Operating PE Ratio | 16.68 |
| Normalized PE Ratio | 24.31 |